阿尔茨海默病中的淀粉样蛋白沉积：其性质与发病机制。 - Suppr

Suppr

超能文献

The amyloid deposits in Alzheimer's disease: their nature and pathogenesis.

作者信息

Glenner G G, Wong C W, Quaranta V, Eanes E D

出版信息

Appl Pathol. 1984;2(6):357-69.

PMID:6242724

Abstract

摘要

相似文献

The amyloid deposits in Alzheimer's disease: their nature and pathogenesis.

Appl Pathol. 1984;2(6):357-69.

Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.

Prog Clin Biol Res. 1989;317:1001-5.

Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.

Lab Invest. 1988 Apr;58(4):454-8.

Human brain pericytes as a model system to study the pathogenesis of cerebrovascular amyloidosis in Alzheimer's disease.

Cell Mol Biol (Noisy-le-grand). 1999 Feb;45(1):37-46.

On causative theories in Alzheimer's disease.

Hum Pathol. 1985 May;16(5):433-5. doi: 10.1016/s0046-8177(85)80078-2.

The blood-brain barrier in Alzheimer's disease.

Can J Neurol Sci. 1986 Nov;13(4 Suppl):446-8. doi: 10.1017/s0317167100037094.

Beta-amyloid: Alzheimer's disease and brain beta-amyloidoses.

Biochemistry (Mosc). 1999 Jul;64(7):752-7.

The neuropathology of Alzheimer's disease.

Neuroimaging Clin N Am. 1995 Feb;5(1):45-57.

Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.

Acta Neuropathol. 2006 Aug;112(2):163-74. doi: 10.1007/s00401-006-0077-5. Epub 2006 Jun 1.

[Molecular pathology in Alzheimer's disease].

Med Clin (Barc). 1988 May 7;90(18):739-42.

引用本文的文献

The history of Down syndrome-associated Alzheimer's disease; past, present, and future.

Alzheimers Dement. 2025 Jun;21(6):e70158. doi: 10.1002/alz.70158.

Brain aging and Alzheimer's disease, a perspective from non-human primates.

Aging (Albany NY). 2024 Oct 29;16(20):13145-13171. doi: 10.18632/aging.206143.

The impact of physical exercise on neuroinflammation mechanism in Alzheimer's disease.

Front Aging Neurosci. 2024 Aug 21;16:1444716. doi: 10.3389/fnagi.2024.1444716. eCollection 2024.

Alzheimer's Disease Neuropathological Change in Aged Non-Primate Mammals.

Int J Mol Sci. 2024 Jul 25;25(15):8118. doi: 10.3390/ijms25158118.

Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging.

J Alzheimers Dis. 2024;100(s1):S153-S164. doi: 10.3233/JAD-240389.

Cerebrospinal fluid/serum albumin ratio in patients with Lewy body disease: a systematic review and meta-analysis.

Front Aging Neurosci. 2024 May 2;16:1390036. doi: 10.3389/fnagi.2024.1390036. eCollection 2024.

Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.

Cell Mol Biol Lett. 2023 Nov 30;28(1):98. doi: 10.1186/s11658-023-00504-2.

Decanoic Acid Rescues Differences in AMPA-Mediated Calcium Rises in Hippocampal CA1 Astrocytes and Neurons in the 5xFAD Mouse Model of Alzheimer's Disease.

Biomolecules. 2023 Sep 27;13(10):1461. doi: 10.3390/biom13101461.

Toward an Early Diagnosis for Alzheimer's Disease Based on the Perinuclear Localization of the ATM Protein.

Cells. 2023 Jun 29;12(13):1747. doi: 10.3390/cells12131747.

5-Nitro-1,2-benzothiazol-3-amine and -Ethyl-1-[(ethylcarbamoyl)(5-nitro-1,2-benzothiazol-3-yl)amino]formamide Modulate α-Synuclein and Tau Aggregation.

ACS Omega. 2023 May 23;8(22):20102-20115. doi: 10.1021/acsomega.3c02668. eCollection 2023 Jun 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The amyloid deposits in Alzheimer's disease: their nature and pathogenesis.

作者信息

Glenner G G, Wong C W, Quaranta V, Eanes E D

出版信息

Appl Pathol. 1984;2(6):357-69.

PMID:6242724

Abstract

摘要

相似文献

The amyloid deposits in Alzheimer's disease: their nature and pathogenesis.

Appl Pathol. 1984;2(6):357-69.

Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.

Prog Clin Biol Res. 1989;317:1001-5.

Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.

Lab Invest. 1988 Apr;58(4):454-8.

Human brain pericytes as a model system to study the pathogenesis of cerebrovascular amyloidosis in Alzheimer's disease.

Cell Mol Biol (Noisy-le-grand). 1999 Feb;45(1):37-46.

On causative theories in Alzheimer's disease.

Hum Pathol. 1985 May;16(5):433-5. doi: 10.1016/s0046-8177(85)80078-2.

The blood-brain barrier in Alzheimer's disease.

Can J Neurol Sci. 1986 Nov;13(4 Suppl):446-8. doi: 10.1017/s0317167100037094.

Beta-amyloid: Alzheimer's disease and brain beta-amyloidoses.

Biochemistry (Mosc). 1999 Jul;64(7):752-7.

The neuropathology of Alzheimer's disease.

Neuroimaging Clin N Am. 1995 Feb;5(1):45-57.

Acta Neuropathol. 2006 Aug;112(2):163-74. doi: 10.1007/s00401-006-0077-5. Epub 2006 Jun 1.

[Molecular pathology in Alzheimer's disease].

Med Clin (Barc). 1988 May 7;90(18):739-42.

引用本文的文献

The history of Down syndrome-associated Alzheimer's disease; past, present, and future.

Alzheimers Dement. 2025 Jun;21(6):e70158. doi: 10.1002/alz.70158.

Brain aging and Alzheimer's disease, a perspective from non-human primates.

Aging (Albany NY). 2024 Oct 29;16(20):13145-13171. doi: 10.18632/aging.206143.

The impact of physical exercise on neuroinflammation mechanism in Alzheimer's disease.

Front Aging Neurosci. 2024 Aug 21;16:1444716. doi: 10.3389/fnagi.2024.1444716. eCollection 2024.

Alzheimer's Disease Neuropathological Change in Aged Non-Primate Mammals.

Int J Mol Sci. 2024 Jul 25;25(15):8118. doi: 10.3390/ijms25158118.

Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging.

J Alzheimers Dis. 2024;100(s1):S153-S164. doi: 10.3233/JAD-240389.

Cerebrospinal fluid/serum albumin ratio in patients with Lewy body disease: a systematic review and meta-analysis.

Front Aging Neurosci. 2024 May 2;16:1390036. doi: 10.3389/fnagi.2024.1390036. eCollection 2024.

Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.

Cell Mol Biol Lett. 2023 Nov 30;28(1):98. doi: 10.1186/s11658-023-00504-2.

Decanoic Acid Rescues Differences in AMPA-Mediated Calcium Rises in Hippocampal CA1 Astrocytes and Neurons in the 5xFAD Mouse Model of Alzheimer's Disease.

Biomolecules. 2023 Sep 27;13(10):1461. doi: 10.3390/biom13101461.

Toward an Early Diagnosis for Alzheimer's Disease Based on the Perinuclear Localization of the ATM Protein.

Cells. 2023 Jun 29;12(13):1747. doi: 10.3390/cells12131747.

5-Nitro-1,2-benzothiazol-3-amine and -Ethyl-1-[(ethylcarbamoyl)(5-nitro-1,2-benzothiazol-3-yl)amino]formamide Modulate α-Synuclein and Tau Aggregation.

ACS Omega. 2023 May 23;8(22):20102-20115. doi: 10.1021/acsomega.3c02668. eCollection 2023 Jun 6.